EVOLUTION OF CANCER TREATMENT COST IN THE LAST 36 MONTHS: AN ANALYSIS FROM A HEALTH PAYER PERSPECTIVE IN BRAZIL

被引：0
|
作者：
Reis Neto, J. P. [1 ]
Busch, J. [2 ]
机构：
[1] CAPESESP, Rio De Janeiro, Brazil
[2] Souza Marques Univ, Rio De Janeiro, RJ, Brazil
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
RWD159
引用
收藏
页码：S391 / S391
页数：1
相关论文
共 50 条
  • [31] EVALUATING COST OF REGIMENS IN HEPATITIS C TREATMENT FROM HEALTHCARE PAYER VIETNAM'S PERSPECTIVE
    Tran, N. N.
    Nguyen, T. T.
    Nguyen, T. L.
    VALUE IN HEALTH, 2017, 20 (09) : A633 - A633
  • [32] ANALYZING THE TREATMENT COST OF LIVER CIRRHOSIS FROM HEALTHCARE PAYER'S PERSPECTIVE OF VIETNAM IN 2015
    Nguyen, D. K.
    Nguyen, T. T.
    Pho, N., V
    VALUE IN HEALTH, 2017, 20 (09) : A633 - A633
  • [33] The economic cost of malaria in Brazil from the perspective of the public health system
    Andrade, Monica, V
    Noronha, Kenya
    Silva, Valeria
    Bracarense, Henrique
    Carvalho, Lucas
    da Silva, Daniel Nogueira
    Souza, Aline
    Motta-Santos, Andre Soares
    Peterka, Cassio
    Castro, Marcia C.
    PLOS GLOBAL PUBLIC HEALTH, 2024, 4 (10):
  • [34] PALLIATIVE TREATMENT AND ITS COST IN THE LAST SIX MONTHS OF LIFE FOR METASTATIC COLORECTAL CANCER PATIENTS
    Merth, G.
    Rumszauer, A.
    Mokrai, D.
    Ruzsa, V
    Fuleki, G.
    Halmai, L.
    Rozsa, P.
    VALUE IN HEALTH, 2018, 21 : S31 - S31
  • [35] SECUKINUMAB VERSUS ETANERCEPT FOR THE TREATMENT OF PSORIASIS: A 52-WEEK COST PER RESPONDER ANALYSIS FROM THE PORTUGUESE PAYER PERSPECTIVE
    Esparteiro, J.
    Silva, C.
    Laires, P. A.
    VALUE IN HEALTH, 2018, 21 : S427 - S427
  • [36] Staplers vs. loop-ligature: a cost analysis from the hospital payer perspective
    Hilsden, Richard
    Khan, Nadia
    Vogt, Kelly
    Schlachta, Christopher M.
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2019, 33 (10): : 3419 - 3424
  • [37] A cost-benefit analysis of smoking cessation prescription coverage from a US payer perspective
    Baker, Christine L.
    Ding, Yao
    Ferrufino, Cheryl P.
    Kowal, Stacey
    Tan, Jenen
    Subedi, Prasun
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2018, 10 : 359 - 370
  • [38] Denosumab for Elderly Men with Osteoporosis: A Cost-effectiveness Analysis from the US Payer Perspective
    Parthan, Anju
    Kruse, Morgan
    Agodoa, Irene
    Silverman, Stuart
    Orwoll, Eric
    JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28
  • [39] A COST-EFFECTIVENESS ANALYSIS COMPARING OBESITY DRUG TREATMENTS FROM A US PAYER PERSPECTIVE
    Gomez-Lumbreras, A.
    Tan, M. S.
    Zapata, Villa L.
    Ilham, S.
    Earl, J. C.
    Malone, D. C.
    VALUE IN HEALTH, 2022, 25 (07) : S335 - S335
  • [40] A Cost-Utility Analysis of Infliximab Compared with Surgery for the Treatment of Ulcerative Colitis; A Public Payer Perspective
    Jones, Jennifer
    Worobetz, Lawrence
    Bedi, Anil
    Manns, Braden
    GASTROENTEROLOGY, 2009, 136 (05) : A172 - A172
12345